Brief introduction of HIV-1 antibodies
Organizer
Speaker
Mengcen Guan
Time
Wednesday, March 1, 2023 9:00 PM - 9:30 PM
Venue
Online
Abstract
Antibody-based anti-HIV-1 treatments have recently advanced from pre-clinical studies to clinical trials, and these trials have demonstrated their potential for disease prevention, maintenance, and prolonged remission. Prevention of multidrug resistance and elimination of the latent reservoir are key factors required for effective treatment and ultimately cure of HIV-1 infection. Our project aims to study the protein–protein binding affinity changes of HIV-1. It is essential to study HIV-1 antibodies.